抑制劑溶液
Metabolism
GPCR/GProtein
Neuroscience
Apoptosis
Chromatin/Epigenetic
TyrosineKinase/Adaptors
Microbiology/Virology
Angiogenesis
CellCycle/Checkpoint
Membranetransporter/Ionchannel
Immunology/Inflammation
DNADamage/DNARepair
Autophagy
CytoskeletalSignaling
StemCells
PI3K/Akt/mTORsignaling
Proteases/Proteasome
MAPK
JAK/STATsignaling
Endocrinology/Hormones
Others
更多…
| 產(chǎn)品編號 | 圖片 | 產(chǎn)品描述 | 分子式 | 加入購物車 | |
|---|---|---|---|---|---|
|
BAY-474，98% | C17H15N5 | |||
|
|
|||||
|
MID-1，98% | C12H11N3O4S | |||
|
|
|||||
|
ROS kinases-IN-1，98% | C20H16N4O | |||
|
|
|||||
|
Hepln-13，98% | C17H13BrN2 | |||
|
|
|||||
|
cFMS Receptor Inhibitor IV，≥98% | C22H26N4O2 | |||
|
|
|||||
|
Vimseltinib，98% | C23H25N7O2 | |||
|
|
|||||
|
ONO-7475，98% | C32H26N4O6 | |||
|
|
|||||
|
Ropsacitinib，98% | C20H17N9 | |||
|
|
|||||
|
CE-245677，98% | C24H22Cl2N6O3 | |||
|
|
|||||
|
AP-C2，98% | C18H16N4S | |||
|
|
|||||
|
LMTK3-IN-1，98% | C18H11F3N4O | |||
|
|
|||||
